SBN sun biomedical limited

"Based on estimated future cashflows to be generated from the...

  1. 6,852 Posts.
    lightbulb Created with Sketch. 2536
    "Based on estimated future cashflows to be generated from the use of the patents, the recoverable amount was
    estimated at $1,781,824 and an impairment loss of $1,000,000 (2007: NIL) recognized. The estimated future cash inflows are based on signed distributor agreements in the US, Australia and Russia. The agreements specify
    minimum quantities and selling price. Cash inflows also include estimated future sales from China, Mexico and
    Europe. For some of these countries there are not signed distributor agreements but management believe the
    estimated sales will be obtained." (Last years final report)


    Hi Sisyphus it was worth 1.7M that is with all the above deals presumed. Now....... it is worth well you guess as I have sold.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.